Diet Programs

Keto Diet / No Carbs Diet For Cancer

Science Center

What science says about Keto Diet / No Carbs Diet For Cancer

The keto diet for cancer has attracted growing interest as a potential approach to cancer treatment. Supporters believe that restricting carbohydrates and promoting ketone production may help target differences in how cancer cells use energy, potentially slowing tumor growth or improving the effects of conventional cancer treatments. Some experimental studies and early clinical research have reported encouraging findings, prompting further investigation into this approach.

However, the use of the ketogenic diet as a cancer treatment remains highly debated. Critics point out that much of the supporting evidence comes from laboratory and animal studies, while clinical evidence in humans remains limited. They also emphasize that cancer cells can use different energy sources and that the effects of the diet may vary depending on the type of cancer. Furthermore, they raise concerns about nutritional deficiencies and unintended weight loss, which can be particularly serious for people with cancer.

The following sections examine the arguments and research presented by supporters and critics of the ketogenic diet, helping to assess its potential role in cancer treatment and the limitations of the available evidence.

 

Experts Views in Favor of the Keto Diet for Cancer 

Some researchers and proponents of the ketogenic diet believe it may have a role in cancer management by targeting the metabolic processes that support cancer cell growth. Their approach is based on the observation that many cancer cells consume large amounts of glucose to meet their energy needs and support rapid multiplication.

According to this theory, significantly restricting carbohydrate intake may reduce the availability of glucose from food and encourage the body to rely more heavily on fat for energy. The liver then produces ketone bodies, which can serve as an alternative fuel for normal cells. Proponents suggest that some cancer cells may have a limited ability to use ketones efficiently, potentially creating a metabolic disadvantage for these cells while allowing normal cells to adapt.

One of the prominent researchers associated with this approach is Dr. Thomas Seyfried, a professor of biology who has published extensively on cancer metabolism. In his book "Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer," he discusses the role of altered cellular energy metabolism in cancer and explores metabolic therapies, including the ketogenic diet, as potential approaches to managing the disease.
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer

Recent clinical research has also begun investigating the ketogenic diet as a complementary approach to cancer treatment.

A 2026 randomized phase II trial titled "A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer" examined whether combining a ketogenic diet with chemotherapy could improve outcomes in patients with metastatic pancreatic cancer. The researchers reported encouraging preliminary results, including longer median progression-free and overall survival in the ketogenic-diet group compared with the group receiving chemotherapy alone. However, the trial was small, and larger studies are needed to confirm these findings.

Another study, published in 2025 and titled "A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma" investigated whether patients with glioblastoma could safely follow a ketogenic diet alongside standard cancer treatment. The study provided initial information about the feasibility and safety of this approach, although it was not designed to establish whether the diet improves survival or controls tumor growth.

These studies have added to interest in the ketogenic diet as a possible complementary approach to cancer treatment and support the need for further clinical investigation.

In addition to scientific research, some cancer patients have shared personal experiences and testimonials on television, social media and other platforms, claiming that following a ketogenic diet helped improve their condition or supported their recovery. These accounts have contributed to public interest in the diet. However, personal testimonials cannot establish that the diet caused an improvement or remission, particularly when patients have also received conventional cancer treatments.

Researchers and supporters therefore believe that targeting cancer metabolism through dietary changes may offer a complementary approach worth investigating, particularly when combined with established cancer treatments.

 

Experts views Against the Keto Diet for Cancer

Other researchers and medical professionals remain cautious about using the ketogenic diet as an approach to cancer management. Their main concern is that much of the encouraging evidence comes from laboratory experiments and animal studies, while clinical research in people remains limited.

One important challenge is that cancer cells do not all rely on glucose in the same way. Although many tumors consume substantial amounts of glucose, cancer cells can also use other nutrients, including fatty acids and amino acids, to support their growth. Their ability to use ketones also varies. Consequently, restricting carbohydrates does not necessarily deprive all cancer cells of the energy they need to survive and multiply.

The American Society of Clinical Oncology (ASCO) has highlighted the lack of sufficient clinical evidence supporting ketogenic diets for cancer management. Its guideline states that there is currently insufficient evidence to recommend either for or against ketogenic or low-carbohydrate diets to improve cancer control, treatment-related side effects or quality of life.

Critics also point out that findings from animal studies cannot automatically be applied to people. For example, the reductions in tumor growth reported in the 2007 mouse study were influenced substantially by calorie restriction. This makes it difficult to attribute the results specifically to the ketogenic diet or to assume that the same effects would occur in human patients.

There are also practical nutritional concerns. Some people with cancer experience poor appetite, digestive problems, unintentional weight loss or muscle loss, which may be worsened by restrictive dietary changes. A high-fat, low-carbohydrate diet may also be difficult for some patients to tolerate, depending on their condition and treatment.

Overall, critics argue that the available clinical evidence is not sufficient to establish the ketogenic diet as an effective cancer treatment. They emphasize that cancer care should continue to rely on treatments supported by clinical evidence, which may include surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy or hormone therapy, depending on the cancer type and stage.

 

Conclusion: Does Science Support the Ketogenic Diet for Cancer?

The ketogenic diet has attracted growing interest as a potential complementary approach to cancer management because of its effects on glucose metabolism, insulin levels and ketone production. Supporters believe that targeting the metabolic requirements of cancer cells may help slow tumor growth and potentially improve the effects of conventional treatments. Some animal studies and early human research have reported encouraging findings, supporting further investigation of this approach.

However, these findings do not yet establish that the ketogenic diet can treat or cure cancer in humans. Cancer cells can use different energy sources, and their metabolic behavior varies between cancer types. Furthermore, clinical studies conducted so far remain limited, and there is insufficient evidence to confirm that following a ketogenic diet improves cancer control or survival.

Overall, the ketogenic diet remains an experimental dietary approach in cancer management rather than an established cancer treatment. Its potential benefits deserve further scientific investigation, but it should not replace surgery, chemotherapy, radiotherapy, immunotherapy or other recommended cancer treatments. Anyone considering this diet after a cancer diagnosis should discuss it with their oncology team and a qualified oncology dietitian to ensure that their nutritional needs and treatment plan are protected.

AposBook Team
Published November 2, 2026

Discussion forum

Please remain authentic and respectful. Aposbook does not endorse any comment and is not responsible for any wrong information provided by users.